These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17685185)

  • 21. Hemorheological disorders and arteriolar resistance during ischemic heart disease.
    Urdulashvili T; Momtselidze N; Mantskava M; Narsia N; McHedlishvili G
    Clin Hemorheol Microcirc; 2004; 30(3-4):399-401. PubMed ID: 15258372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis.
    Maisel AS; Peacock WF; McMullin N; Jessie R; Fonarow GC; Wynne J; Mills RM
    J Am Coll Cardiol; 2008 Aug; 52(7):534-40. PubMed ID: 18687247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 24. Cystatin C in acute heart failure without advanced renal impairment.
    Naruse H; Ishii J; Kawai T; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Matsui S; Nomura M; Hishida H; Ozaki Y
    Am J Med; 2009 Jun; 122(6):566-73. PubMed ID: 19393984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of apoptosis markers in advanced heart failure patients.
    Niessner A; Hohensinner PJ; Rychli K; Neuhold S; Zorn G; Richter B; Hülsmann M; Berger R; Mörtl D; Huber K; Wojta J; Pacher R
    Eur Heart J; 2009 Apr; 30(7):789-96. PubMed ID: 19196721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT; Nikolaou M; Birmpa D; Farmakis D; Paraskevaidis I; Bistola V; Katsoulas T; Filippatos G; Kremastinos DT
    Am J Cardiol; 2009 Jan; 103(1):73-5. PubMed ID: 19101233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heart failure in the elderly: do differences in etiology and pathophysiology require different therapeutic strategies? Pros].
    Frigerio M; Oliva F
    Ital Heart J; 2003 Dec; 4 Suppl 8():39S-44S. PubMed ID: 15005530
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis.
    López-Longo FJ; Oliver-Miñarro D; de la Torre I; González-Díaz de Rábago E; Sánchez-Ramón S; Rodríguez-Mahou M; Paravisini A; Monteagudo I; González CM; García-Castro M; Casas MD; Carreño L
    Arthritis Rheum; 2009 Apr; 61(4):419-24. PubMed ID: 19333979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure.
    Alehagen U; Dahlström U
    Int J Cardiol; 2009 Apr; 133(2):233-40. PubMed ID: 18407361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
    Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
    J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of heart rate turbulence assessment in patients with chronic heart failure.
    Szymanowska K; Piatkowska A; Nowicka A; Michalski M; Dankowski R; Kandziora M; Biegalski W; Wierzchowiecki M; Poprawski K
    Kardiol Pol; 2008 Dec; 66(12):1289-95. PubMed ID: 19169975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure.
    Kupper N; Gidron Y; Winter J; Denollet J
    Psychosom Med; 2009 Nov; 71(9):973-80. PubMed ID: 19834046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of interleukin-4 and IgE levels with LDL oxidation in atherosclerosis.
    Shahzad F; Tawwab S; Afzal N
    Iran J Immunol; 2010 Jun; 7(2):109-16. PubMed ID: 20574124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperuricemia in acute heart failure. More than a simple spectator?
    Alimonda AL; Núñez J; Núñez E; Husser O; Sanchis J; Bodí V; Miñana G; Robles R; Mainar L; Merlos P; Darmofal H; Llácer A
    Eur J Intern Med; 2009 Jan; 20(1):74-9. PubMed ID: 19237097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between serum uric acid and perioperative and late cardiovascular outcome in patients with suspected or definite coronary artery disease undergoing elective vascular surgery.
    Dunkelgrun M; Welten GM; Goei D; Winkel TA; Schouten O; van Domburg RT; van Gestel YR; Flu WJ; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Oct; 102(7):797-801. PubMed ID: 18805100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O; Paz H; Ammar R; Yaniv N; Schliamser JE; Lewis BS
    Isr Med Assoc J; 2008 Feb; 10(2):109-12. PubMed ID: 18432021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Uric acid, apo-E and apo-C3 correlation in normo- and hyperlipidemia].
    Boĭko ER; Ovechkin AO; Kaneva AM; Potolitsyna NN; Boĭko SG
    Ter Arkh; 2007; 79(12):51-4. PubMed ID: 18220032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.